Polycystic kidney disease: Pathogenesis and potential therapies-Reference-Cited by-同舟云学术

Polycystic kidney disease: Pathogenesis and potential therapies

Published:2011-10 Issue:10 Volume:1812 Page:1337-1343
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Takiar Vinita,Caplan Michael J.

Funder

NIH

Department of Defense

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference153 articles.

1. Autosomal dominant polycystic kidney disease: the last 3years;Torres;Kidney Int.,2009

2. Autosomal dominant polycystic kidney disease;Torres;Lancet,2007

3. Polycystic kidney disease;Wilson;N. Engl. J. Med.,2004

4. Mosaicism in autosomal dominant polycystic kidney disease revealed by genetic testing to enable living related renal transplantation;Connor;Am. J. Transplant.,2008

5. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome;Consugar;Kidney Int.,2008

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical Manifestation of Adult Polycystic Kidney Disease in an Elderly Individual;Cureus;2024-02-27

2. Mechanosensitive protein polycystin-1 promotes periosteal stem/progenitor cells osteochondral differentiation in fracture healing;Theranostics;2024

3. Modulating inflammation with interleukin 37 treatment ameliorates murine Autosomal Dominant Polycystic Kidney Disease;Kidney International;2023-12

4. Metabolism-based approaches for autosomal dominant polycystic kidney disease;Frontiers in Molecular Biosciences;2023-02-16

5. Predictors of progression to end-stage renal disease among patients with polycystic kidney disease type 1 in Alexandria Governorate Egypt;Journal of The Egyptian Society of Nephrology and Transplantation;2023